Search Results - "Fiebig, Heiner H"

Phase II preclinical drug screening in human tumor xenografts : a first european multicenter collaborative study by BOVEN, E, WINOGRAD, B, BERGER, D. P, DUMONT, M. P, BRAAKHUIS, B. J. M, FODSTAD, Ø, LANGDON, S, FIEBIG, H. H

“…In a European joint project carried out in 6 laboratories a disease-oriented program was set up consisting of a panel of 7 tumor types, each represented by 4…”
Get full text

Alkyl and Alkoxyethyl Antineoplastic Phospholipids by Koufaki, Maria, Polychroniou, Vanessa, Calogeropoulou, Theodora, Tsotinis, Andrew, Drees, Markus, Fiebig, Heiner H, LeClerc, Sophie, Hendriks, Hans R, Makriyannis, Alexandros

“…Two series of phosphodiester ether lipid analogs with (N-methylmorpholino)ethyl or (N-methylpiperidino)ethyl polar head groups and long aliphatic or…”
Get full text

Abstract 3835: Ex vivo 3D assay: rapid and reliable replication of the in vivo anti-tumor efficacy of c-Met inhibitors by Gorynia, Sabine, Guo, Jianing, Ackermann, Andreas, Maier, Armin, Krumbach, Rebekka, Kelter, Gerhard, Vuaroqueaux, Vincent, Metz, Thomas, Metcalfe, Thomas, Fiebig, Heiner H.

“…For compounds directed against molecular targets expressed in tumor cells, the ex vivo 3D tumor clonogenic assay (TCA) is a rapid and reliable ex vivo assay…”
Get full text

Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin by Hofmann, J, Fiebig, H H, Winterhalter, B R, Berger, D P, Grunicke, H

“…We have shown previously that the flavonoid quercetin (3,3',4',5,7-pentahydroxyflavone) enhances the antiproliferative activity of…”
Get more information

Is there any correlation between MDR1, GST-pi-expression and CEA? by Weissenberger, C, Fiebig, H H, Lutterbach, J, Barke, A, Momm, F, Müller, M, Witucki, G, Guttenberger, R, Berger, D P

“…The levels of mRNA-expression of multidrug resistance (MDR1) and glutathione-S-transferase pi (GST-pi) were measured and correlated with the…”
Get more information

Clinical phase I and pharmacokinetic trial of vinorelbine administered as single intravenous bolus every 21 days in cancer patients by SCHILLING, T, FIEBIG, H. H, KERPEL-FRONIUS, S, WINTERHALTER, B, VARIOL, P, TRESCA, P, HEINRICH, B, HANAUSKE, A.-R

“…We have performed a high-dose clinical and pharmacokinetic trial with vinorelbine administered as a bolus injection every 21 days. The aim was to evaluate a…”
Get full text

Detection of monosomy in interphase nuclei and identification of marker chromosomes using biotinylated alpha-satellite DNA probes by Kiechle-Schwarz, M, Decker, H J, Berger, C S, Fiebig, H H, Sandberg, A A

“…Nonradioactive in situ hybridization with chromosome-specific highly repetitive DNA probes is a fast and easy method for the detection of the number of…”
Get more information